Verastem, Inc. - Special Call Transcript
Good morning, and welcome to the Verastem Oncology Investor Conference Call on Friday, February 28, 2020. (Operator Instructions) Please be advised that this call is being recorded at the company's request and will be available on the company's website for a period of 90 days from today.
At this time, I would like to introduce Mr. John Doyle, Vice President of Investor Relations and Finance at Verastem Oncology. Please go ahead.
Welcome, everyone, and thank you for joining us this morning. With me today to discuss Verastem Oncology's announcement regarding its new strategic direction are Brian Stuglik, Chief Executive Officer; Dan Paterson, President and Chief Operating Officer; and Rob Gagnon, Chief Financial and Business Officer.
During today's call, Brian will provide some introductory remarks; Dan will provide an overview of the new strategic direction and realignment initiatives; and then Rob will provide an overview of financial information relating to today's announcements; Brian will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |